EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Sickle cell disease in Jharkhand: A registry-based evaluation of disease burden and healthcare needs

Anupa Prasad, Aradhana Kumari, Krishna Kumar, Partha Kumar Chaudhuri, Sunil Shakya, Ganesh Chauhan, Sushma Kumari, Arun Vincent Kisku, Amit Kumar, Rishi Tuhin Guria

The Indian Journal of Medical Research · 28.02.2026 · 163 · 88-94

DOI: 10.25259/ijmr_1644_2025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Indian Journal of Medical Research, online erschienen am 28.02.2026. Verfasst von Anupa Prasad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India. Hauptthemen laut MEDLINE: Anemia, Sickle Cell. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Sickle cell disease poses a significant healthcare burden across several regions and states in India. We present findings from a sickle cell anaemia registry in the State of Jharkhand, a tribal predominant state situated in Eastern India, to provide an insight into the clinico-epidemiological profile and need-based management of sickle cell anaemia.

Methods

Sickle cell disease Registry at Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand was started in the year 2022 and it has 334 sickle cell disease patients recruited over two and a half years. This clinical research provides systematically captured comprehensive data of sickle cell anaemia patients with HbSS genotype, including demographics, clinical presentation, laboratory findings, treatment modalities, complications, and their outcomes.

Results

Clinical manifestations varied from mild to severe, with the most common presentation being vaso-occlusive crises (n=257, 94.5%). A significant proportion of patients required blood transfusion n=260, (95.6%). Hydroxyurea the mainstay of treatment, was taken regularly by 136, (50%) of patients, whereas n=68, 25% were irregularly taking hydroxyurea medication and n= 68, 25% never took it. Regular intake of hydroxyurea therapy was significantly associated with reduction in pain crises and a decreased need for blood transfusion. Interpretation and conclusions Establishment of hydroxyurea monitoring units, monitoring of blood transfusion through appropriate investigations, increased utilisation of iron chelation therapy, and identification of patients with increased stroke risk can lead to improved patient care, escalated awareness and reduced rate of hospitalisation in sickle cell disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellHumansRegistriesIndiaVaso-Occlusive CrisesHydroxyureaFemaleMaleAdolescentAdultBlood TransfusionChildCost of Illness

Stichwörter der Autor:innen

HemoglobinopathiesHydroxyurea therapyJharkhandRegistrySickle cell diseaseVaso-occlusive crisis

Substanzen

Hydroxyurea

Autor:innen und Institutionen

  • Department of Biochemistry, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
  • Department of Genetics and Genomics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
  • Department of Paediatrics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
  • Department of Transfusion Medicine and Advanced Blood Centre, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
  • Department of Laboratory Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
  • Department of Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.

Zitieren

APA

Prasad, A., Kumari, A., Kumar, K., Chaudhuri, P. K., Shakya, S., Chauhan, G., Kumari, S., Kisku, A. V., Kumar, A., & Guria, R. T. (2026). Sickle cell disease in Jharkhand: A registry-based evaluation of disease burden and healthcare needs. The Indian Journal of Medical Research, 163, 88-94. https://doi.org/10.25259/ijmr_1644_2025

Vancouver

Prasad A, Kumari A, Kumar K, Chaudhuri PK, Shakya S, Chauhan G, et al. Sickle cell disease in Jharkhand: A registry-based evaluation of disease burden and healthcare needs. The Indian Journal of Medical Research. 2026;163:88-94. doi:10.25259/ijmr_1644_2025

BibTeX
@article{Prasad2026,
  author = {Prasad, Anupa and Kumari, Aradhana and Kumar, Krishna and Chaudhuri, Partha Kumar and Shakya, Sunil and Chauhan, Ganesh and Kumari, Sushma and Kisku, Arun Vincent and Kumar, Amit and Guria, Rishi Tuhin},
  title = {Sickle cell disease in Jharkhand: A registry-based evaluation of disease burden and healthcare needs},
  journal = {The Indian Journal of Medical Research},
  year = {2026},
  volume = {163},
  pages = {88--94},
  doi = {10.25259/ijmr_1644_2025}
}
Kostenlos starten →